0001179110-20-003312.txt : 20200309
0001179110-20-003312.hdr.sgml : 20200309
20200309171535
ACCESSION NUMBER: 0001179110-20-003312
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200305
FILED AS OF DATE: 20200309
DATE AS OF CHANGE: 20200309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Manning Anthony M.
CENTRAL INDEX KEY: 0001716468
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50797
FILM NUMBER: 20698852
MAIL ADDRESS:
STREET 1: C/O PALATIN TECHNOLOGIES, INC.
STREET 2: 4B CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001235010
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043561634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 491-9700
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgar.xml
FORM 4 -
X0306
4
2020-03-05
0
0001235010
MOMENTA PHARMACEUTICALS INC
MNTA
0001716468
Manning Anthony M.
C/O MOMENTA PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Scientific Officer
Common Stock
2020-03-05
4
A
0
15000
0
A
20068
D
Common Stock
2020-03-06
4
S
0
7310
29
D
12758
D
Restricted Stock Units
2020-03-05
4
A
0
15000
0
A
Common Stock
15000
15000
D
Shares received pursuant to settlement of Performance Stock Units that were granted on October 17, 2018.
This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Each Restricted Stock Unit represents a contingent right to receive one share of MNTA Common Stock.
Subject to the officer's continued employment with the company, the Restricted Stock Units will vest on March 5, 2021.
/s/ R. Mark Chamberlin as attorney in fact
2020-03-09